The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
Self-citationYang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
Self-citationTumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Self-citationp63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
Self-citationp63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 802
Self-citationKnudson, A. G. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001311 · Cited by 559
On the shoulders of giants: p63, p73 and the rise of p53
Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 486
Self-citationGaiddon, C., Lokshin, M., Ahn, J., Zhang, T., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1874-1887.2001 · Cited by 464
AIS is an oncogene amplified in squamous cell carcinoma
Hibi, K., Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratovitski, E. A., Jen, J., & Sidransky, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5462 · Cited by 463
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
Chemosensitivity linked to p73 function
Irwin, M. S., Kondo, K., Marin, M. C., Cheng, L. S., Hahn, W. C., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00078-3 · Cited by 408
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 318
Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer
Urist, M. J., Di Como, C. J., Lu, M.-L., Charytonowicz, E., Verbel, D., Crum, C. P., Ince, T. A., McKeon, F. D., & Cordon-Cardo, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64396-9 · Cited by 257
Self-citationPhysical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities
Strano, S., Fontemaggi, G., Costanzo, A., Rizzo, M. G., Monti, O., Baccarini, A., Del Sal, G., Levrero, M., Sacchi, A., Oren, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201405200 · Cited by 226
Frequent alteration of p63 expression in human primary bladder carcinomas.
Park, B.-J., Lee, S. J., Kim, J. I., Lee, S., Lee, C. H., Chang, S. G., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 209
Koga, F., Kawakami, S., Fujii, Y., et al. (2003) · PubMed · Cited by 153
Concin, N., Becker, K., Slade, N., Erster, S. H., Mueller-Holzner, E., Ulmer, H., Daxenbichler, G., Zeimet, A. G., Zeillinger, R., Marth, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1060 · Cited by 138
Hagiwara, K., McMenamin, M. G., Miura, K., & Harris, C. C. (1999) · PubMed · Cited by 122
Role of the newer p53 family proteins in malignancy
Irwin, M. S., & Kaelin, W. G. (2001) · APOPTOSIS · doi:10.1023/a:1009663809458 · Cited by 85
p63 and p73 are not required for the development and p53-dependent apoptosis of T cells
Senoo, M., Manis, J. P., Alt, F. W., & McKeon, F. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.005 · Cited by 81
Self-citationP63 expression in normal, hyperplastic and malignant breast tissues
Wang, X., Mori, I., Tang, W., Nakamura, M., Nakamura, Y., Sato, M., Sakurai, T., & Kakudo, K. (2002) · Breast Cancer · doi:10.1007/bf02967592 · Cited by 78
Puig, P., Capodieci, P., Drobnjak, M., Verbel, D., Prives, C. L., Cordon‐Cardo, C., & Como, C. J. D. (2003) · PubMed · Cited by 69
Analysis of p73 in human borderline and invasive ovarian tumor
Ng, S.-W., Yiu, G. K., Liu, Y., Huang, L., Palnati, M., Jun, S. H., Berkowitz, R. S., & Mok, S. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203512 · Cited by 66
Ahomadegbe, J. C., Tourpin, S., Kaghad, M., Zelek, L. H., Vayssade, M., Mathieu, M. C., Rochard, F., Spielmann, M., Tursz, T., Caput, D., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203914 · Cited by 49
Nozaki, M., Tada, M., Kashiwazaki, H., Hamou, M., Diserens, A., Shinohe, Y., Sawamura, Y., Iwasaki, Y., de Tribolet, N., & Hegi, M. E. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00400.x · Cited by 37
p73-Mediated Chemosensitivity: A Preferential Target of Oncogenic Mutant p53
Strano, S., & Blandino, G. (2003) · Cell Cycle · doi:10.4161/cc.2.4.426 · Cited by 37
Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia
Yamaguchi, H., Inokuchi, K., Sakuma, Y., & Dan, K. (2001) · Leukemia · doi:10.1038/sj.leu.2402265 · Cited by 27
Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas
Chen, Y. K., Huse, S., & Lin, L. (2003) · Clinical Otolaryngology · doi:10.1046/j.1365-2273.2003.00743.x · Cited by 25
Expression of p63 (TA and ▴N isoforms) in human primary well differentiated buccal carcinomas
Chen, Y.-K., Hsue, S., & Lin, L. (2004) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2003.10.023 · Cited by 21
Chen, Y.-K., Hsue, S., & Lin, L. (2004) · Head & Neck · doi:10.1002/hed.20098 · Cited by 21
Chen, Y.-K., Huse, S., & Lin, L. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.0374.x · Cited by 19
Inokuchi, K., Hamaguchi, H., Taniwaki, M., Yamaguchi, H., Tanosaki, S., & Dan, K. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1181 · Cited by 7
Research works printed but not linked: 4
- Knudson, 1975, Genetics of human cancer, Genetics, 79, 305
- Moll, 2003, The role of p63 and p73 in tumor formation and progression: Coming of age toward clinical usefulness, Clin. Cancer Res., 9, 5437
- Park, 2004, Low expression of p63 and p73 in osteosarcoma, Tumori, 90, 239, 10.1177/030089160409000214 · doi:10.1177/030089160409000214
- Yamamoto, 2002, Expression of p73 gene, cell proliferation and apoptosis in breast cancer: Immunohistochemical and clinicopathological study, Oncol. Rep., 9, 729
Cited by
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Metadata
- Authors
- Flores, E. R., Sengupta, S., Miller, J. B., Newman, J. J., Bronson, R., Crowley, D., Yang, A., McKeon, F., & Jacks, T.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 7
- Issue
- 4
- Pages
- 363-373
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2005013681
- Cited by
- 502
- References
- 35
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3029 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.